In vitro experiments corroborated these findings, demonstrating that EphA8 overexpression potentially accelerates OSCC progression by augmenting tumor cell invasion, rather than proliferation capacity when using SCC-25 and H357 cancer cells (31). Here, EPHA8 is linked to neoplasm.